Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2016 ∙ de Oliveira, L. H. Camacho, L. A. Coutinho, E. S. Martinez-Silveira, M. S. Carvalho, A. F. Ruiz-Matus, C. Toscano, C. M.

Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review

  • Americas
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2016 ∙ Dyda, A. Karki, S. Hayen, A. MacIntyre, C. R. Menzies, R. Banks, E. Kaldor, J. M. Liu, B.

Influenza and pneumococcal vaccination in Australian adults: A systematic review of coverage and factors associated with uptake

  • Western Pacific
  • Australia
  • Adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ La Torre, G. Mannocci, A. Colamesta, V. D'Egidio, V. Sestili, C. Spadea, A.

Influenza and pneumococcal vaccination in hematological malignancies: A systematic review of efficacy, effectiveness, and safety

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Ciapponi, A. Lee, A. Bardach, A. Glujovsky, D. Rey-Ares, L. Luisa Cafferata, M. Valanzasca, P. Garcia Marti, S.

Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
  • Safety
  • Economic aspects
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Barbieri, Marco Capri, Stefano

Is vaccination good value for money? A review of cost-utility analyses of vaccination strategies in eight european countries

  • Europe
  • All age groups
  • Human papillomavirus (HPV)
  • Pneumococcal disease
  • Varicella
  • Influenza
  • Rotavirus
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Harris, J. A. Moniz, M. H. Iott, B. Power, R. Griggs, J. J.

Obesity and the receipt of influenza and pneumococcal vaccination: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Oligbu, G. Hsia, Y. Folgori, L. Collins, S. Ladhani, S.

Pneumococcal conjugate vaccine failure in children: A systematic review of the literature

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Burgess, L. Southern, K. W.

Pneumococcal vaccines for cystic fibrosis

  • Children
  • Adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2016 ∙ Herdman, M. Cole, A. Hoyle, C. K. Coles, V. Carroll, S. Devlin, N.

Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • Hepatitis B
  • Hepatitis E
  • Measles
  • Meningococcal disease
  • Rotavirus
  • Varicella
  • Influenza
  • Pneumococcal disease
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Ewald, H. Briel, M. Vuichard, D. Kreutle, V. Zhydkov, A. Gloy, V.

The Clinical Effectiveness of Pneumococcal Conjugate Vaccines A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
Loading...